- Exchange: OTC US
- Sector: Industrials
- Industry: Electrical Equipment
- Sub-Industry: Comm & Res Bldg Equip & Sys
Global Immune Technologies Inc
+ Add to WatchlistGIMU:US
0.0690 USD 0.0140 25.45%As of 20:10:00 ET on 06/18/2013.
Snapshot for Global Immune Technologies Inc (GIMU)
| Open: | 0.0501 | Day's Range: | 0.0501 - 0.0690 | Volume: | 5,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.0550 | 52wk Range: | 0.0021 - 0.1100 | 1-Yr Rtn: | +762.50% |
Key Statistics for GIMU
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | 0.0000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1.81 |
| Shares Outstanding (M) | 26.29 |
| 30 Day Average Volume | 42,941 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GIMU
Company Profile & Key Executives for GIMU
Global Immune Technologies, Inc. owns all rights and interests to the drug Trioxolane. The drug acts to reinforce the natural immune system and regulate the production of serotonin, prostaglandin and inflammatory interleukins.
| Serge TalonChairman/President/CEO | Jeffrey R BruhjellCFO/Secretary |
| Alejandro Bellapart-HeineVP:Global Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GIMU News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page